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Regulatory T (Treg) cells are essential for mainte-
nance of immune homeostasis. Here we found that
hydrogen sulfide (H2S) was required for Foxp3
+
Treg cell differentiation and function and that H2S
deficiency led to systemic autoimmune disease.
H2S maintained expression of methylcytosine dioxy-
genases Tet1 and Tet2 by sulfhydrating nuclear tran-
scription factor Y subunit beta (NFYB) to facilitate its
binding to Tet1 and Tet2 promoters. Transforming
growth factor-b (TGF-b)-activated Smad3 and inter-
leukin-2 (IL-2)-activated Stat5 facilitated Tet1 and
Tet2 binding to Foxp3. Tet1 and Tet2 catalyzed
conversion of 5-methylcytosine (5mC) to 5-hydroxy-
methylcytosine (5hmC) in Foxp3 to establish a Treg-
cell-specific hypomethylation pattern and stable
Foxp3 expression. Consequently, Tet1 and Tet2
deletion led to Foxp3 hypermethylation, impaired
Treg cell differentiation and function, and autoim-
mune disease. Thus, H2S promotes Tet1 and Tet2
expression, which are recruited to Foxp3 by TGF-b
and IL-2 signaling to maintain Foxp3 demethylation
and Treg-cell-associated immune homeostasis.
INTRODUCTION
Regulatory T (Treg) cells are a distinct lineage of CD4+ T cells that
are indispensable in maintaining immune homeostasis and sup-
pressing inflammatory reactions (Vignali et al., 2008). The fork-
head-family transcription factor Foxp3 is specifically expressed
in Treg cells and plays a crucial role in Treg cell lineage specifi-
cation and function (Hori et al., 2003). Foxp3 deficiency results
in fatal autoimmune disorders in both mice and humans (She-vach, 2000). Treg cell development, differentiation, and function
are governed by multiple epigenetic regulation mechanisms,
such as DNAmethylation, histonemodifications, and particularly
DNA demethylation of Foxp3 promoter and conserved non-cod-
ing DNA sequence (CNS) elements (Kim and Leonard, 2007;
Zheng et al., 2010). However, it remains unknown how cell
signaling and epigenetic modification are synergistically coordi-
nated to determine Treg cell lineage differentiation and achieve
cell identity. DNAmethylation has a profound impact on genome
stability, gene transcription, and molecular and cellular re-
sponses. Recent studies indicate that the Ten eleven transloca-
tion (Tet) family is capable of converting 5-methylcytosine (5mC)
to 5-hydroxymethylcytosine (5hmC) to erase existing methyl-
ation marks (Kohli and Zhang, 2013), which serve as an impor-
tant epigenetics regulation mechanism (Koh et al., 2011; Song
et al., 2013). However, the roles of Tet and 5hmC in immune sys-
tems, especially in Treg cell development, differentiation, and
function, are unknown.
Hydrogen sulfide (H2S), an endogenous gasotransmitter, is
capable of regulating various endogenous signaling pathways.
In mammals, H2S is mainly generated by two pyridoxal-5
0-phos-
phate-dependent enzymes, termed cystathionine b-synthase
(CBS) and cystathionine g-lyase (CSE) (Wang, 2002). Impaired
H2S metabolism might be associated with immune disorders,
cancer, and hypertension (Peng et al., 2014; Szabo et al.,
2013). H2S might accentuate the inflammatory process in
burn-injury-induced inflammation and lung injury caused by bac-
terial sepsis (Li et al., 2005; Zhang et al., 2010). On the other
hand, providing H2S through its donor might be beneficial in
the treatment of colitis (Fiorucci et al., 2007), asthma (Zhang
et al., 2013), and systemic lupus erythematosus (SLE) (Han
et al., 2013). One of the mechanisms by which H2S regulates
inflammation is by sulfhydrating reactive Cys residues in target
proteins to increase their catalytic activity (Paul and Snyder,
2012). However, the role of H2S in inflammation is still under
debate and the molecular mechanisms of H2S in immune regula-
tion remain largely unknown.Immunity 43, 251–263, August 18, 2015 ª2015 Elsevier Inc. 251
Figure 1. H2S-Deficient T Cells Show
Impaired Treg Cell Differentiation
(A) H2S production in CD4
+ T cell culture super-
natant after treatment with CBS inhibitor HA, CSE
inhibitor PAG, HA and PAG combination, or H2S
donor NaHS.
(B–D) CBS and CSE expression in CD4+ T cells
from mouse spleen (Spl), lymph nodes (LN), and
thymus (Thy) are analyzed by flow cytometry (B),
immunoblot (C), and PCR (D).
(E) Cbs and Cse expression in different T cells
subsets including naive, Th0, Th1, Th2, Th17, and
Treg cells (iTreg and nTreg) are shown, as as-
sessed by qPCR analysis.
(F) H2S production in Treg cell culture supernatant
in indicated groups.
(G) The frequency of Treg cells in spleen and lymph
nodes after 5 weeks of HA (n = 4), PAG (n = 4), or
HA and PAG combined (n = 4) treatment in mice
are shown, as assessed by flow cytometry.
(H) The mouse serum concentrations after HA,
PAG, or HA and PAG combined injection are
shown.
Statistical significance is determined with one-way
ANOVA (A, F–H). *p< 0.05, **p < 0.01, ***p< 0.001,
(mean ± SD). Results are from three repeated ex-
periments.In this study, we show that Tet-mediated demethylation of
Foxp3, in conjunction with signaling modulation, dynamically
controls Treg cell lineage determination. H2S deficiency results
in reduced Tet1 and Tet2 expression, which leads to hyperme-
thylation of Foxp3 and, eventually, impairment of Treg cell differ-
entiation and function and immune homeostasis.
RESULTS
Treg Cells Express CBS and CSE and Produce H2S
Abnormal H2S metabolism has been linked to defects in immune
homeostasis, andwe revealed that CD4+ T cells produced H2S in
culture supernatant and that the production was downregulated
by treatment with CBS inhibitor hydroxylamine (HA) or CSE inhib-
itor D, L-propargylglycine (PAG); conversely, H2S concentration
was upregulated by treatment with H2S donor NaHS. Combined
treatment with HA and PAG showed similar H2S decrease as
observed in the groups that received HA or PAG individually (Fig-
ure1A).CD4+Tcells fromspleen, lymphnodes, and thymusofWT
mice expressedbothmRNAandprotein ofCBSandCSE (Figures
1B–1D). Expression of Cbs and Cse in Treg cells were elevated
compared to other CD4+ T cell subsets (Figure 1E). Treg cells
also produced H2S in the culture supernatant, which was regu-
lated by H2S inhibitor HA and PAG or H2S donor (Figure 1F).
H2S-Deficient Mice Show Treg Cell Deficiency and
Autoimmune Disease
Treatment with the H2S inhibitors HA and PAG led to reduced
Treg cell numbers in mouse spleen and lymph nodes with a
similar reduction observed with combined or single HA and
PAG treatment (Figures 1G, 1H, and S1A). Moreover, HA, PAG,
or HA and PAG treatment reduced Treg cell differentiation
in vitrowhen culturedwith different doses of TGF-b1 (Figure S1B;
Chen et al., 2003).252 Immunity 43, 251–263, August 18, 2015 ª2015 Elsevier Inc.To further examine whether H2S serves as a physiologic gaso-
transmitter for regulating T cells, we analyzed Treg cell differen-
tiation and function in H2S-deficient (Cbs
/) mice (Figures S2A
and S2B; Watanabe et al., 1995). Cbs/ mouse serum showed
decreased concentrations of H2S compared to control ones (Fig-
ure S2C). CD4+ T cells fromCbs/mice also produced less H2S
when cultured in vitro (Figure S2D). Consistent with H2S inhibitor
HA and PAG treatment, the proportion of Foxp3+ Treg cells were
reduced in the spleen and lymph nodes of Cbs/ mice
compared to control littermates (Figure 2A). The total number
of Treg cells was also diminished in Cbs/ mice (Figure 2B).
Cbs/ T cells showed compromised in vitro Treg cell differenti-
ation when cultured with different doses of TGF-b1 (Figure 2C).
Moreover, CD4+Foxp3+ Treg cells from Cbs/ mice exhibited
a reduced capacity to suppress CD4+CD25 T cells, as as-
sessed by an in vitro coculture assay (Figure 2D). To validate
these findings, we generated Cbs/Foxp3GFP mice by crossing
Cbs+/mice with Foxp3GFPmice. As expected,Cbs/Foxp3GFP
mice showed reduced numbers of GFP-labeled Treg cells
compared to Foxp3GFP mice (Figure 2E). Moreover, Foxp3
expression was reduced in Cbs/ Treg cells, as indicated by
reduced mean fluorescence intensity (MFI) (Figure 2F). We
observed that autoreactive antibodies, including total immuno-
globulin M (IgM) (Figure 2G), anti-nuclear antibody (ANA) (Fig-
ure 2H), and anti-double strand DNA (dsDNA) IgG and IgM
antibodies (Figure 2I), weremore abundant in serum fromCbs/
mice compared to control ones. Cbs/ mice were born in ex-
pected Mendelian ratios and appeared grossly normal at the
newborn stage. However, they started to lose body weight at
4 weeks of age and had a high incidence of death that might
be due to inflammation of multiple organs, including the colon,
lung, and liver (Figures 2J–2L and S2E). We found a consistent
decrease in the proportion of Treg cells in the lung, gut, and liver
of Cbs/ mice (Figure S2F). Analysis of peripheral CD4+ T cells
Figure 2. H2S-Deficient Mice Show Treg
Cell Impairment and Autoimmune Diseases
(A) Treg cell frequency in control and Cbs/ mice
spleen (Spl) and lymph nodes (LN) are assessed by
flow cytometry.
(B) The total numbers of Foxp3+ Treg cells in
control and Cbs/ mice.
(C) Control and Cbs/ naive T cells in vitro dif-
ferentiation induced by 2 ng/ml IL-2 and a range of
doses of TGF-b are shown.
(D) Suppressive assay of Treg cells from control
and Cbs/ mice.
(E and F) Treg cell frequency (E) and Foxp3 (F)
expression in spleen of Foxp3GFP and Cbs/
Foxp3GFP mice are assessed by flow cytometry.
(G–I) Auto-reactive antibodies including anti-au-
toactive antibody IgM (G), anti-nuclear antibody
(ANA) (H), and dsDNA antibodies IgM and IgG (I) in
control andCbs/mouse serum aremeasured by
ELISA (n = 6).
(J) Kaplan-Meier survival curves of Cbs/ mice
(n = 10) and control littermates (n = 10).
(K) Histological structures of the mouse colon,
lung, and liver at 5–6 weeks are shown, as as-
sessed by hematoxylin and eosin (HE) staining.
Inflammation cells infiltration is indicated (blue
triangle).
(L) CD3+ lymphocyte infiltration (yellow triangle) in
colon, lung, and liver is analyzed by immunofluo-
rescence staining.
Statistical significance is determined by two-tailed
Student’s t tests (A–I), Kaplan-Meier survival
curves are constructed and analyzed by a log-rank
test (J, p < 0.001); *p < 0.05, **p < 0.01, ***p <
0.001 (mean ± SD). Scale bars represent HE,
100 mm. Immunofluorescence staining, 50 mm.
Results are from three repeated experiments.obtained from peripheral lymphoid organs showed that effector
T cell numbers were elevated in Cbs/ mice (Figure S2G).
Cbs/ mice showed increased numbers of CD4+IL-17+ and
CD4+IFN-g+ cells in the peripheral lymphoid organs compared
to control ones, though there was no difference in the number
of IL-4+ cells (Figures S2H and S2I), whereas CD4+ cell distribu-
tions in the peripheral lymphoid organs of Cbs/ mice were
similar to the control group (Figure S2J). To verify the role of
H2S in Treg cell development, we generatedmixed bonemarrow
chimeras by injecting C57BL/6 (CD45.1+) control bone marrow
with Cbs/ (CD45.2+) bone marrow into sublethally irradiated
WT recipient mice. We showed that the recipient mice had a
reduced proportion of CD4+Foxp3+ Treg cells originating from
Cbs/ bonemarrow compared to those originating from control
mice (Figure S2K), indicating that endogenous H2S production
plays an essential role in Treg cell generation. To examine
whether inflammation in Cbs/ mice is an autoimmune
response, we transferred CD4+ naive T cells, derived from con-
trol and Cbs/ mice, into Rag1/ mice and found that Cbs/
T cells elicited a more severe immune response, as indicated by
signs of severe colitis and more body weight loss compared to
the control group (Figures S2L–S2O). Co-transferring Cbs/
Treg cells failed to prevent development of colitis in Rag1/
mice, confirming the compromised suppressive capacity ofCbs/ Treg cells (Figures S2L–S2O). These data suggest that
H2S deficiency is associated with the development of autoim-
mune disease.
H2S Promotes Immune Homeostasis via Regulating Treg
Cells
To further determine whether Treg cell deficiency accounted for
autoimmunity in Cbs–/– mice, we transferred WT Treg cells into
Cbs/ mice and found that Treg cell transfer increased body
weight of Cbs/ mice (Figure 3A). The elevated levels of autor-
eactive antibodies including anti-IgM, ANA, and anti-ds DNA
antibodies in Cbs/ mice were partially blocked by Treg cell
transfer (Figures 3B–3D). Moreover, survival analysis indicated
that WT Treg cell transfer (n = 6) extended lifespan of Cbs/
mice (n = 10) (Figure 3E). The elevated inflammatory cell infiltra-
tion observed in the colon, liver, and lung of Cbs/ mice was
also rescued by Treg cell infusion (Figure 3F). These results indi-
cate that Treg cell deficiency at least partially accounts for the
autoimmunity developed in Cbs/ mice. Microarray and gene
set enrichment analysis (GSEA) of CD4+ T cells from Cbs/
and control mice (Figures S3A and S3B) showed reduced
expression of Foxp3-related genes in Cbs/ mice (Figure S3B).
The downregulated expression of Foxp3-related genes in CD4+
T cells by qPCR validated the microarray data. Moreover, theImmunity 43, 251–263, August 18, 2015 ª2015 Elsevier Inc. 253
Figure 3. H2S Is Required for Maintenance
of Immune Homeostasis via Regulating
Treg Cells
(A–E) Mouse body weight (A), autoreactive anti-
bodies, including anti-autoactive antibody IgM (B),
ANA (C), and anti-dsDNA antibodies IgM and IgG
(D), and mouse survival curves (E) with or without
H2S donor GYY4137 injection (n = 6) or Treg cell
infusion (n = 6) are shown.
(F) HE staining shows the histological structure of
colon, lung, and liver in indicated groups. Inflam-
matory cell infiltration is indicated by blue triangle.
Scale bar represents 100 mm.
(G) Proportion of Foxp3+ Treg cells after GYY4137
injection in control and Cbs/ mice.
Statistical significance is determined by one-way
ANOVA (A–D, G), Kaplan-Meier survival curves are
constructed and analyzed by a log-rank test
(E, Cbs/ versus control: p < 0.001; Cbs/+Treg
versus Cbs/: p < 0.05; Cbs/+Treg versus
control: p < 0.05; Cbs/+GYY versus Cbs/: p <
0.01; Cbs/+GYY versus control: p < 0.05); *p <
0.05, **p < 0.01, ***p < 0.001 (mean ± SD). Results
are from three repeated experiments.expression of Foxp3-related genes was downregulated in
Cbs/ Treg cells (Figure S3C; Zheng et al., 2007), suggesting
that H2S deficiency might affect expression of Foxp3 and its
downstream genes.
We next examined whether H2S donor treatment could rescue
Treg cell numbers and autoimmunity phenotypes inCbs/mice
and showed that injection of H2S donor GYY4137 (Figure S3D)
resulted in increased serum H2S concentrations and body
weight (Figures 3A and S3E). The elevated autoreactive anti-
bodies in Cbs/ mice were partially decreased after H2S donor
treatment along with an extended lifespan and decreased in-
flammatory cell infiltration in the colon, liver, and lung of Cbs/
mice (Figures 3B–3F). The frequency of Treg cells was elevated
by GYY4137 treatment inCbs/mice (Figure 3G). There was no
obvious change in control mice when receiving H2S donor treat-
ment (Figures 3A–3G). These results indicate that elevating H2S
levels are capable of restoring immune homeostasis and Treg
cell numbers in Cbs/ mice.
H2S-deficiency-induced homocysteine (Hcy) accumulation
might contribute to disease phenotypes in patients (Kelly et al.,
2003). Because Hcy concentrations are higher in Cbs/ mouse
serum than in control mouse serum (Liu et al., 2014), we treated
mice with Hcy and found that Hcy failed to affect Treg cell
numbers (Figure S3F). These data indicate that H2S, but not
homocysteine, regulates Treg cells.254 Immunity 43, 251–263, August 18, 2015 ª2015 Elsevier Inc.Analysis of AnnexinV, 7AAD, and Ki67
showed that the rate of apoptosis and
proliferation in CD4+Foxp3+ Treg cells
from Cbs/ and control mice were
similar (Figures S3G and S3H).
H2S Targets Tet1 and Tet2 to
Regulate Hydroxylation of 5mC
BecauseCbs–/– Treg cells had decreased
expression of Foxp3 and its target genes,including CD25, GITR, and CTLA-4 (Figure S4A), we used qPCR
and immunoblot analysis to confirm that Cbs/ Treg cells had
decreased expression of Foxp3 (Figures 4A and S4B). We next
examined why H2S-deficient Treg cells express reduced amount
of Foxp3 and found thatCbs–/– T cells expressed similar levels of
phosphorylated Smad3 and Stat5 to those of control cells
treated by TGF-b1 or IL-2 in vitro (Figures S4C and S4D), which
indicates that H2S-regulated Foxp3 expression in Treg cells
might not be due to altered response to TGF-b and IL-2
signaling. Foxp3 expression is controlled by its promoter region
and intragenic enhancer elements CNS1–3 (Zheng et al., 2010).
CpG motifs in CNS2 are demethylated in Treg cells, which are
known to be required for stable Foxp3 expression (Floess
et al., 2007). Therefore, we examined the methylation status of
the promoter and CNS2 in Foxp3 locus. CD4+CD25+ Treg cells
and CD4+CD25 T conventional (Tconv) cells were isolated
and their methylation status was analyzed (Kim and Leonard,
2007). In comparison to Treg cells, Tconv cells showed high
amounts of methylation in the promoter and CNS2 of Foxp3 lo-
cus. However, Treg cells from Cbs/ mice displayed elevated
methylation in the promoter and CNS2 of Foxp3 locus compared
to Treg cells from control mice (Figure 4B), suggesting that H2S
plays a functional role in DNA demethylation of Foxp3 locus.
Genomic DNA is mainly methylated by DNA methyltransferases
(Dnmt family members), although it can be demethylated in
Figure 4. H2S Targets Tet1 and Tet2 to Convert 5mC to 5hmC
(A) Foxp3 expression in control and Cbs/ Treg cells are shown.
(B) The methylation status in promoter and CNS2 region of Fopx3 in control and Cbs/ CD4+CD25 Tconv cells and Treg cells analyzed by OxBS sequencing.
Each row of dots represents CpG sites in Foxp3 promoter and CNS2 region; each dot represents a single CpG. Empty dots indicate unmethylated CpGs; black
dots indicate methylated CpGs.
(C and D) The expression of Tet1, Tet2, and Tet3 in CD4+ T cells from control and Cbs/ mice are assessed by qPCR (C) and immunoblot (D).
(E) Tet1 and Tet2 expression in CD4+ T cells treated with H2S donor NaHS are shown.
(F and G) Enrichments of 5hmC (F) and 5mC (G) in Foxp3 promoter and CNS1–3 regions are assessed by hMeDIP-qPCR andMeDIP-qPCR analysis, respectively.
IgG was used as a control.
(H and I) 5hmC expression in CD4+ T cells are assessed by immunofluorescence staining (H) and dot blot assay analysis (I). Scale bar represents 25 mm.
(J) Global 5hmC expression in CD4+ T cells treated by H2S donor NaHS are shown.
Statistical significance is determined by two-tailed Student’s t tests (C) or one-way ANOVA (F and G). *p < 0.05, **p < 0.01, ***p < 0.001 (mean ± SD). Results are
from three repeated experiments.multiple ways, including Tet-mediated 5mC hydroxylation (Kohli
and Zhang, 2013). We found that Dnmt expression was not
altered in Cbs/ CD4+ T cells (Figure S4E). The Tet family con-
tributes to DNA demethylation by converting 5mC to 5hmC and
has recently been implicated in epigenetic regulation of cell re-
programming and differentiation (Tahiliani et al., 2009). By immu-
noblot and qPCR analysis, we found that H2S deficiency led to
downregulation of Tet1 and Tet2, but not Tet3, in CD4+ T cells
(Figures 4C, 4D, and S4F). H2S inhibitors HA or PAG treatment
resulted in downregulation of Tet1 and Tet2 in CD4+ T cells (Fig-
ures S4G and S4H), whereas treatment with H2S donor NaHS
rescued Tet1 and Tet2 expression in Cbs/ CD4+ T cells (Fig-
ures 4E and S4I). These data suggest that H2S is required for
maintenance of Tet1 and Tet2 expression.Tet-mediated active DNA demethylation within Foxp3 might
be involved in Treg cell development (Toker et al., 2013). We
next investigated whether H2S regulated 5hmC enrichment
within Foxp3 locus and found that 5hmC enrichment was
decreased within Foxp3 promoter, CNS2, and CNS3 in Cbs/
Treg cells compared to the control ones, as assessed by
hMeDIP-qPCR analysis (Figure 4F). In contrast, 5mC enrichment
was elevatedwithin Foxp3 promoter, CNS2, andCNS3 inCbs/
Treg cells (Figure 4G). These data suggest that H2S might regu-
late 5hmC enrichment in Foxp3 locus. We next assessed
whether H2S modified the epigenetic landscape by affecting
5hmC levels in the genome. Dot blot assays and immunofluores-
cence analysis showed that global 5hmC levels were decreased
in Cbs/ CD4+ T cells (Figures 4H and 4I). More importantly,Immunity 43, 251–263, August 18, 2015 ª2015 Elsevier Inc. 255
H2S donor NaHS treatment rescued global 5hmC levels in a
time-dependent manner (Figure 4J). Because Foxp3 promoter
and CNS element epigenetic marks play important roles in deter-
mining Treg cell identity, we examinedwhether H2Swas required
to stabilize the expression of Foxp3. We found that Cbs/ Treg
cells had reduced Foxp3 expression compared to the corre-
sponding Foxp3GFP Treg cells after 3 days of culture in vitro
(Figure S4J). Moreover, Cbs/ Treg cells were much easier to
differentiate into Th1 and Th17 cells, but not into Th2 cells,
when cultured in vitro (Figures S4K–S4M). Taken together, these
data suggest that H2S-mediated enrichment of 5hmC in Foxp3
locus might contribute to Treg cell differentiation, function, and
stability.
H2S Regulates Tet1 and Tet2 Expression via
Sulfhydration of NFYB
Tet enzyme expression is under tight transcriptional regulation.
For instance, OCT4 and C/EBPa directly associate with Tet1
and Tet2 promoters and regulatory elements to regulate their
expression in pluripotent stem cells and myeloid lineage cells
(Kallin et al., 2012; Koh et al., 2011). Because analysis of Tet1
and Tet2 promoters (Transfec, Biobase) showed conserved
CCAAT binding motif for NFY, which is a well-characterized het-
erotrimeric transcriptional activator (NFYA, NFYB, and NFYC),
we verified that NFYB bound to the promoters of Tet1 and
Tet2 by ChIP-qPCR analysis. This binding was decreased in
Cbs/ CD4+ T cells. When treated with H2S donor, but not
H2S substrate L-cysteine, NFYB binding to Tet1 and Tet2 pro-
moters were restored in Cbs/ T cells (Figure 5A), indicating
that H2S might facilitate NFYB binding to Tet1 and Tet2
promoters. Knockdown of Nfyb by siRNA led to decreased
expression of Tet1 and Tet2 as well as partially suppressed
H2S-induced upregulation of Tet1 and Tet2 in CD4
+ T cells (Fig-
ures 5B, 5C, and S5A). However, we found that Cbs/ and con-
trol cells expressed similar amounts of NFYB (Figure 5D).
Ubiquitination at Lys138 is important for NFYB transcriptional
activation (Nardini et al., 2013), implying that proteinmodification
might regulate NFYB activity. H2Smediates signal response pre-
dominantly by sulfhydrating cysteines of target proteins such as
GAPDH and actin, leading to augmentation of GAPDH catalytic
activity and actin polymerization (Mustafa et al., 2009). Sulfhy-
dration (SHY) is a physiological process in which H2S attaches
an additional sulfur to the thiol (-SH) group of a cysteine, yielding
a hydropersulfide (-SSH) (Sen et al., 2012). We employed Alexa
Fluor 488-conjugated C5maleimide (greenmaleimide), which in-
teracts selectively with sulfhydryl groups of cysteines, to label
both sulfhydrated and unsulfhydrated cysteines. Dithiothreitol
(DTT) treatment was used to selectively cleave disulfide bonds
and detach the green signal from sulfhydrated protein only, re-
sulting in decreased fluorescence (Figure 5E).We used the green
maleimide to detect overall protein sulfhydration in T cell lysates.
In control T cells, we detected green bands representing pro-
teins with SH and SSH in the presence of L-cysteine and
observed a 50% reduction of the green signal after DTT treat-
ment. Green signals were also detected in Cbs/ T cells;
however, DTT treatment failed to reduce the green signals (Fig-
ure S5B). DTT treatment abolished the green NFYB signal in
the presence of L-cysteine in control T cells, indicating sulfhydra-
tion of NFYB. In contrast, inCbs/ T cells, DTT did not affect the256 Immunity 43, 251–263, August 18, 2015 ª2015 Elsevier Inc.green NFYB signal, indicating absence of NFYB sulfhydration in
Cbs/ T cells (Figure 5F). Treatment with H2S donor NaHS
improved sulfhydration of NFYB in control T cells and also
restored sulfhydration of NFYB in Cbs/ T cells (Figure 5G).
We next employed liquid chromatography-mass spectrometric
analysis (LC-MS) to identify the cysteine residue responsible
for sulfhydration of NFYB under H2S donor treatment (Liu
et al., 2014). The mass shift suggested that the cysteine residues
(C) were sulfhydrated at the C105 site of NFYB after H2S donor
treatment (Figures 5H and S5C). To verify the effect of sulfhydra-
tion on NFYB binding to Tet1 and Tet2 activity, we used diamide
(DM), which is capable of reducing the number of sulfhydryls and
thereby reducing protein sulfhydration (Kosower et al., 1969), to
pretreat Cbs/ T cells. ChIP-qPCR results showed that DM
treatment blocked H2S donor-induced rescue of NFYB binding
to Tet1 and Tet2 promoters (Figure 5I). To further confirm that
sulfyhydration of NFYB cysteine residues played a critical role
in H2S-mediated Tet1 and Tet2 expression, we generated Nfyb
C105 mutation constructs (Nfyb C105A) and overexpressed
Nfyb andNfybC105A in CD4+ T cells (Figures 5J and S5D). Over-
expression of Nfyb elevated Tet1 and Tet2 expression, espe-
cially under H2S donor treatment (Figures 5K and 5L). However,
overexpression ofNfybC105A failed to upregulate expression of
Tet1 and Tet2 either with or without H2S donor treatment (Fig-
ures 5K and 5L), indicating that H2S-regulated Tet1 and Tet2
expression in CD4+ T cells depends at least partially on the sulf-
hydration of NFYB C105. These results suggest that H2S-medi-
ated sulfhydration of NFYB is important for NFY complex binding
to Tet1 and Tet2 promoters to regulate their expression.
Loss of Tet1 and Tet2 Impair Treg Cell Differentiation
and Function
In order to verify the role of Tet1 and Tet2 in immune homeo-
stasis and Treg cell differentiation and function, we generated
Tet1/Cd4CreTet2fl/fl double knockout (Tet DKO) mice (Fig-
ure S6A) and found that they developed inflammation in multiple
organs, including the colon, lung, and liver (Figure 6A), along
with infiltration of abundant CD3-positive cells (Figure S6B),
decreased body weight (Figure S6C), and several elevated
autoreactive antibodies, including anti-dsDNA IgG (Figure 6B)
and IgM (Figure 6C) antibodies, and ANA (Figure 6D) in the pe-
ripheral blood. Treg cell frequencies in TetDKOmicewere signif-
icantly decreased in spleen and lymph nodes compared to the
control group (Figure 6E). In addition, total numbers of Treg cells
were decreased in Tet DKOmice (Figure 6F). Tet DKO Treg cells
also showed reduced Foxp3 expression (Figures 6G–6I). These
results indicate that Tet1 and Tet2 depletion led to reduction of
Treg cell frequency and Foxp3 expression. The proportion of
Treg cells was also consistently decreased in the lung and liver
in Tet DKO mice (Figure S6D). Moreover, Treg cells from Tet
DKO mice showed reduced capacity to suppress CD4+CD25
cells, as assessed by in vitro coculture assay (Figure 6J). The
experimental data imply that Tet1 and Tet2 are required formain-
tenance of immune homeostasis and Treg cell differentiation and
function.
Next, we generated mixed bone marrow chimeras to confirm
the intrinsic role of Tet1 and Tet2 in CD4+Foxp3+ Treg cell gen-
eration. We injected C57BL/6 (CD45.1+) bone marrow with Tet
DKO (CD45.2+) bone marrow into sublethally irradiated WT
Figure 5. H2S Regulates Tet1 and Tet2 Expression via Sulfhydration of NFYB
(A) NFYB enrichments in the promoters of Tet1 and Tet2 are analyzed by ChIP-qPCR.
(B and C) The expression of Tet1 and Tet2 in CD4+ T cells after indicated treatment are assessed by immunoblot (B) and qPCR (C).
(D) Immunoblot demonstrating NFYB expression in control and Cbs/ T cells.
(E) Schematic diagram for detection of NFYB sulfhydration with green maleimide.
(F and G) The green signal of NFYB protein after indicated treatment (L-cysteine in F and NaHS in G) in control and Cbs/ T cells.
(H) LC-MS analysis of sulfhydration in NFYB protein Cys105 after NaHS (1 mM) treatment.
(I) ChIP-qPCR analyzes NFYB enrichment in the promoters of Tet1 and Tet2 in Cbs/ T cells in indicated treatments.
(J) NFYB expression in CD4+ T cells without or with Nfyb or Nfyb C105A plasmids transfection are analyzed by immunoblot.
(K and L) The expression of Tet1 and Tet2 in CD4+ T cells after indicated treatments are assessed by immunoblot (K) and qPCR (L).
Statistical significance is by one-way ANOVA (A, C, I, L). **p < 0.05, **p < 0.01, ***p < 0.001 (mean ± SD). Results are from three repeated experiments.recipient mice. We revealed that the recipient mice had a
reduced proportion and number of CD4+Foxp3+ Treg cells orig-
inating from Tet DKO mouse bone marrow compared to those
originating from the control ones (Figures 6K and 6L), indicating
that Tet1 and Tet2 intrinsically regulate Treg cell differentiation.
T cells from Tet DKO mice displayed slightly decreased Treg
cell differentiation in the presence of TGF-b and IL-2 (Figure S6E).Furthermore, Tet1 and Tet2 depletion resulted in reduced global
5hmC levels in CD4+ T cells (Figure S6F) and 5hmC enrichment
within Foxp3 promoter, as well as CNS2 and CNS3 in Treg cells,
as assessed by hMeDIP-qPCR (Figure 6M). The enrichment of
5mC within Foxp3 promoter and CNS2 were elevated in Tet
DKO Treg cells, as assessed by MeDIP-qPCR (Figure 6N). We
found that Tconv cells from both Tet DKO and control miceImmunity 43, 251–263, August 18, 2015 ª2015 Elsevier Inc. 257
Figure 6. Tet1 and Tet2 Are Required for Treg Cell Differentiation and Function
(A) HE staining show inflammatory cell infiltration (blue triangle) in the colon, lung, and liver of Tet1/Cd4CreTet2fl/fl (Tet DKO) mice; Tet2fl/fl mice are used as
control. Scale bar represents 100 mm.
(B–D) The anti-dsDNA antibodies IgM (B) and IgG (C) and anti-ANA (D) are measured by ELISA in control and Tet DKO mouse serum.
(E) Treg cell frequencies in the spleen (Spl) and lymph nodes (LN) from control and Tet DKO mice are shown.
(F) The total numbers of Foxp3+ Treg cells are shown.
(G–I) Foxp3 expression in control and Tet DKO Treg cells are assessed by flow cytometry (G), immunoblot (H), and qPCR (I).
(J) Suppressive capacities of Tet DKO Treg cells and control ones are shown.
(K and L)WT control (CD45.1) and TetDKO (CD45.2) bonemarrow cells co-transferred into sublethally irradiatedWT recipient mice (n = 4) for 6 weeks to generate
mixed bone marrow chimeric mice. Representative flow cytometry plots of splenic CD45.1 and CD45.2 cells are shown. Percentages (K) and numbers (L) of
CD4+Foxp3+ Treg cells are shown.
(M and N) Enrichments of 5hmC (M) and 5mC (N) within Foxp3 promoter and CNS1–3 regions in control and Tet DKO Treg cells are assessed by hMeDIP-qPCR
and MeDIP-qPCR analysis, respectively. IgG is used as a control.
(O) OxBS-sequencing analysis shows the promoter and CNS2 region methylation status of Foxp3 in Treg cells.
Statistical significance is determined by two-tailed Student’s t tests (B–G, I–L) and one-way ANOVA (M and N). *p < 0.05, **p < 0.01, ***p < 0.001 (mean ± SD).
Results are from three repeated experiments.were high methylated in the Foxp3 promoter and CNS2 region,
and Tet1 and Tet2 depletion resulted in reduced DNA demethy-
lation in T cells compared to controls (Figures 6O and S6G).
Similar to Cbs/ Treg cells, Tet1- and Tet2-depleted Treg cells258 Immunity 43, 251–263, August 18, 2015 ª2015 Elsevier Inc.expressed reduced amounts of Foxp3 after 3 days in vitro cul-
ture. Tet DKO Treg cells were much easier to differentiate into
Th1 and Th17 cells, but not into Th2 cells, when cultured
in vitro (Figures S6H–S6K).
To verify the role of Tet1 and Tet2 in Treg cell differentiation
and function, we showed that WT control Treg cells adaptively
transferred into Tet DKOmice were capable of ameliorating sys-
temic inflammatory phenotypes, as shown by reduction of the
elevated levels of autoreactive antibodies, improvement of histo-
pathological alteration in the colon, liver, and lung, elevation of
the body weight, and extension of mouse lifespan (Figures
S6L–S6Q). We next generated Tet1/Foxp3CreTet2fl/fl double
knockout (Tet KO) mice and found that these mice developed
similar inflammation phenotypes to those observed in Tet DKO
mice, such as multiple organ inflammation, elevated autoreac-
tive antibodies, decreased body weight, and higher incidence
of death (Figures S6L–S6Q). In addition, Tet KO mice showed
decreased Treg cell frequency and Foxp3 expression in Treg
cells (Figures S6R and S6S). Taken together, these results indi-
cate that Tet1 and Tet2 are required for Foxp3 demethylation
and Treg cell differentiation and function.
Smad3 and Stat5 Recruit Tet Proteins to Foxp3 Locus
Previous studies showed that 5hmC colocalized with Tet1 at
high and intermediate GpG-content sequences (Xu et al.,
2011). To investigate whether Foxp3 is a direct target of Tet1
and Tet2, we showed that Tet1 and Tet2 bound to Foxp3 pro-
moter and CNS1–3 regions with different enrichment levels,
which were decreased in Cbs/ Treg cells compared to the
control group (Figure 7A). Because TGF-b and IL-2 play indis-
pensable roles in Treg cell development, differentiation, and
cell identity (Chen et al., 2003; Feng et al., 2014; Konkel
et al., 2014; Li et al., 2014), we examined whether TGF-b and
IL-2 signaling regulate Tet1 and Tet2 expression and found
that TGF-b and IL-2 treatment failed to affect expression of
Tet1 and Tet2 or global 5hmC levels in T cells (Figures 7B
and 7C). Because Tet1 and Tet2 can interact with other mole-
cules, such as NANOG, to synergistically regulate cell signaling
for reprogramming (Costa et al., 2013), we assessed whether
TGF-b and IL-2 treatment regulated Tet1 and Tet2 interaction
with protein complexes in T cells. We used LC-MS analysis
to show that Smad3 and Stat5a interacted with both Tet1
and Tet2 in CD4+ T cells and Treg cells (Figures S7A–S7C,
Table S1). Next, we performed immunoprecipitation to show
that Tet1 and Tet2 co-immunoprecipitated with Smad3 and
Stat5 to a higher degree in Treg cells compared to CD4+
T cells. TGF-b and IL-2 treatment enhanced co-immunoprecip-
itation of Smad3 and Stat5 with Tet1 and Tet2 in T cells
whereas TGF-b- and IL-2-neutralizing antibody attenuated the
co-immunoprecipitation of Smad3 and Stat5 with Tet1 and
Tet2 in Treg cells (Figure 7D). Stat5 binds to Foxp3 promoter
and CNS2 region, serving as a key regulator to open CNS2 re-
gion to maintain Treg cell identity, and CNS1 is a TGF-b-sensi-
tive element that contains binding sites for NFAT and SMADs
(Feng et al., 2014; Ogawa et al., 2014). Treg cells showed
higher enrichment of Tet1 and Tet2 on Foxp3 promoter and
CNS2 compared to CD4+ T cells (Figures 7E and 7F). To deter-
mine the role of TGF-b and IL-2 in regulating Tet1 and Tet2
binding to Foxp3 locus, we showed that TGF-b and IL-2 treat-
ment elevated Tet1 and Tet2 binding to Foxp3 promoter, CNS1
and CNS2, but not CNS3 in CD4+ T cells, whereas TGF-b- and
IL-2-neutralizing antibody treatment abolished Tet1 and Tet2
binding to Foxp3 locus in Treg cells (Figures 7E and 7F). Toverify the roles of protein interaction and recruitment in Foxp3
demethylation, CD4+CD25Foxp3GFP T cells from control or
Tet DKO mice were transferred to Rag1/ mice and a fraction
of CD4+Foxp3GFP+ cells were generated. These cells showed
progressive demethylation of Foxp3 promoter and CNS2
regions (Figure 7G). Moreover, CD4+Foxp3GFP+ from the Tet
DKO T cell transfer group showed reduced demethylation
compared to the control group at Foxp3 promoter and CNS2
region. Smad3 and Stat5 knockdown decreased demethylation
of Foxp3 promoter and CNS2 compared to the scramble
control group (Figures 7G and S7D). Taken together, these
findings indicate that TGF-b and IL-2 activated Smad3 and
Stat5, recruiting Tet1 and Tet2 binding to Foxp3 locus to
regulate Foxp3 demethylation and Treg cell differentiation and
function.
H2S Donor Treatment Rescues Treg Cell Deficiency in
Cbs–/– Mice in a Tet-Dependent Manner
We next examined whether rescue of Treg cell deficiency by H2S
donor depended on Tet1 and Tet2 and found that H2S donor
NaHS treatment failed to rescue Treg cell number decrease in
Tet DKO mice (Figure 7H). When we infused Tet1- and Tet2-
overexpressed CD4+CD25Foxp3GFP T cells to Rag1/
mice, the Tet1 and Tet2 overexpression group had an increased
numbers of CD4+Foxp3+ Treg cells relative to the control group
(Figures 7I and S7E). We further analyzed Tet1 and Tet2 ex-
pression in CD4+ T cells from H2S donor GYY4137 injection
mice and found that Tet1 and Tet2 was elevated after
GYY4137 treatment in Cbs/ mice (Figures 7J and S7F).
HMeDIP-qPCR analysis showed that GYY4137 injection
elevated 5hmC enrichment within the Foxp3 locus in Treg cells
from Cbs/ mice (Figure 7K). These data indicate that the role
of H2S in regulating Treg cell differentiation and function de-
pends on Tet-mediated demethylation.
DISCUSSION
We showed that reduced levels of H2S were responsible for the
impairment of CD4+Foxp3+ Treg cell differentiation and function
and systemic autoimmune disease observed in mice. Adminis-
tration of H2S donor could rescue Treg-cell-deficient and sys-
temic autoimmune phenotypes in Cbs/ mice and WT Treg
cell infusion could also partially rescue autoimmunity in Cbs/
mice, suggesting that H2S is indispensable for Treg-cell-associ-
ated immune homeostasis.
Epigenetic modifications, especially DNA methylation, play
an important role in immune system and Foxp3+ Treg cell dif-
ferentiation and lineage stabilization (Ichiyama et al., 2015;
Kim and Leonard, 2007; Tsagaratou et al., 2014). Tet expres-
sion is important for Foxp3 demethylation in the thymus and
peripheral Treg cells and might play an essential role in Treg
cell development, differentiation, and function as well as the
maintenance of immune homeostasis (Nair and Oh, 2014;
Toker et al., 2013; Wang et al., 2013). Our results showed
that deletion of Tet1 and Tet2 resulted in systemic autoimmune
disease due to a substantial reduction and impairment of Treg
cell differentiation and function. Tet-deleted Treg cells showed
substantially reduced enrichment of 5hmC within Foxp3 pro-
moter and CNS elements, which might be responsible forImmunity 43, 251–263, August 18, 2015 ª2015 Elsevier Inc. 259
Figure 7. Activated Smad3 and Stat5 Recruit Tet1 and Tet2 Binding to Foxp3 Locus
(A) ChIP-qPCR analyzes Tet1 and Tet2 binding in the promoter and CNS regions of Foxp3 in Treg cells. IgG is used as control.
(B and C) Tet1 and Tet2 expression (B) and global 5hmC levels (C) in CD4+ T cells treated with TGF-b and IL-2 are assessed by immunoblot and dot blot assay,
respectively.
(D) Tet1 and Tet2 interaction with Smad3 and Stat5 in CD4+ T cells and Treg cells by indicated treatments are assessed by protein complex immunoprecipitation
(Co-IP) assay.
(E and F) Tet1 (E) and Tet2 (F) binding activity to the promoter and CNS1-3 regions of Foxp3 in CD4+ T cells and Treg cells are analyzed by ChIP-qPCR.
(G) CD4+CD25Foxp3GFP T cells from control and Tet DKOmice are transferred into Rag1/ mice (n = 4). The generated CD4+Foxp3GFP+ cells are isolated for
methylation analysis and show the demethylation ratios of Foxp3 promoter and CNS2 in indicated groups.
(H) Treg cell frequencies inCbs/mice (n = 4) and TetDKOmice (n = 4) with or without GYY4137 (GYY) injection (n = 4) are shown, as assessed by flow cytometry.
(I) Treg cell frequency inRag1/mice (n = 4) after transferring control,CBS/, or Tet1- and Tet2-overexpressedCbs/CD4+ naive T cells, as assessed by flow
cytometry.
(J) Tet1 and Tet2 expression in CD4+ T cells after GYY4137 injection in Cbs/ mice are shown.
(K) 5hmC enrichment within the promoter and CNS1–3 regions of Foxp3 in Treg cells with or without GYY4137 injection in Cbs/ mice are analyzed by
hMeDIP-qPCR.
Statistical significance is determined by one-way ANOVA (A, E, F, H, I, K). *p < 0.05, **p < 0.01, ***p < 0.001 (mean ± SD). Results are from three repeated
experiments.
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Treg cell deficiency. However, whether Tet family members
regulate other types of cells in the immune system still needs
further investigation. DNA methylation and demethylation are
regulated by multiple factors (Wu and Zhang, 2014). Cbs/
and Tet DKO Treg cells showed hypermethylation at Foxp3
promoter and CNS2, with variable methylation ratio per cell.
Based on Foxp3 expression, Treg cells can be classified into
Foxp3lo, Fopx3med, and Foxp3hi subsets. Among these, the
Foxp3lo subset was substantially reduced in Foxp3 CNS2
knockout mice (Li et al., 2014), implying that different Treg
cell subsets might be regulated differently based on Foxp3
expression or methylation.
The H2S-medidated protein sulfhydration might affect its reg-
ulatory effects on inflammatory processes and vasorelaxation
(Paul and Snyder, 2012). H2S could sulfhydrate NFYB to control
its binding activity to Tet1 and Tet2 promoters, and thus regu-
late Tet1 and Tet2 expression in Treg cells. This might illustrate
the underlying mechanism of how sulfhydration was involved in
inflammatory processes. Strikingly, H2S-mediated sulfhydration
might represent a new protein modification approach to regu-
late NFYB function, similar to the ubiquitination of NFYB at
Lys138 to regulate transcriptional activation (Nardini et al.,
2013). H2S affected sulfhydration of NFYB to control NFYB
complex binding to the promoters of Tet1 and Tet2, forming
a H2S-NFYB-Tet axis, thus regulating Treg cell differentiation
and function. Tet-mediated 5mC hydroxylation has been de-
tected in a broad range of cell types and extensively studied
in embryonic stem cells (ESCs), brain cells, and neurons (Kriau-
cionis and Heintz, 2009; Tahiliani et al., 2009). H2S exerts multi-
faceted and important effects on the central nervous system
and NFY is required for maintenance of ESC properties and
neuronal cell functions (Grskovic et al., 2007; Yamanaka
et al., 2014). These pieces of evidence suggest that the H2S-
NFYB-Tet regulation cascade might be applicable to other
cell types.
Tet1 binds to target genes either to regulate the metabolism of
5mC at CpG-rich sequences by converting it to 5hmC or to regu-
late transcription. For example, Tet1 is involved in transcriptional
repression through its interaction with the SIN3A complex (Wil-
liams et al., 2011) and establishes cell pluripotency through its
interaction with NANOG (Costa et al., 2013). We showed that
phosphorylated Smad3 and Stat5, upon stimulation by TGF-b
and IL-2, facilitated Tet1 and Tet2 binding to Foxp3 locus. This
was achieved via the formation of a protein complex, leading
to the enrichment of 5hmC to promote Foxp3 expression and
Treg cell differentiation and function. Stable Treg cell lineage
establishment requires concurrent expression of the transcrip-
tion factor Foxp3 and establishment of Treg-cell-specific hypo-
methylation pattern (Ohkura et al., 2012). Our study indicates
that Treg cell lineage determination and maintenance require
synergistic regulation by signaling pathway and epigenetic
modification, in which Tet1 and Tet2 are required for the dynamic
process that establishes and maintains hypomethylation of
Foxp3.
In conclusion, physiological levels of H2S are required to
maintain immune homeostasis by regulating Tet expression
in T cells. Treg cell lineage determination and maintenance
require synergistic regulation by signaling pathway and epige-
netic modification.EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (JAX #000664), B6.SJL-Ptprca (JAX #002014, CD45.1+), B6.129S7-
Rag1tm1Mom/J (JAX #002216, Rag1/), B6.129P2-Cbstm1Unc/J (JAX #002461,
Cbs+/), B6.Cg-Foxp3tm2Tch/J (JAX #006772, Foxp3GFP), B6.129S4-
Tet1tm1.1Jae/J (JAX #017358, Tet1+/), B6.129S-Tet2tm1.1Iaai/J (JAX #017573,
Tet2fl/fl), and Tg (Cd4-cre)1Cwi/BfluJ (JAX #017336, Cd4Cre) mice were pur-
chased from Jackson Lab. To generate Cbs/Foxp3GFP mice, we mated
Cbs+/ mice with Cbs+/Foxp3GFP mice. To generate Tet1/Cd4CreTet2fl/fl
mice, we mated Tet1+/Cd4CreTet2fl/+ mice with Tet1+/Tet2fl/fl mice. To
generate Tet1/Cd4CreTet2fl/flFoxp3GFP mice, we mated Tet1+/Cd4Cre
Tet2fl/+Foxp3GFP mice with Tet1+/Tet2fl/fl mice. All animal experiments were
performed under institutionally approved protocols for the use of animal
research at the University of Southern California (USC#11141, 11953, and
11327) and University of Pennsylvania (IACUC# 805478).
Adoptive Transfer Colitis
Rag1/ mice were injected intravenously with 4 3 105 FACS-sorted naive
CD4+CD25CD45RBhi cells from control or Cbs/ mice, without or with
control or Cbs/ 2 3 105 Treg cells. After T cell reconstitution, mice were
monitored weekly and samples were harvested 6 weeks later for further
investigation.
Generation of Mixed Bone Marrow Chimeric Mice
Bone marrow cells were isolated from femurs and tibias of donor animals
(Tet1/Cd4CreTet2fl/fl CD45.2 or Cbs/ CD45.2 and WT CD45.1). C57BL/6
WT mice received sublethal irradiation (10 Gy). At 6 hr after irradiation,
Tet1/Cd4CreTet2fl/fl CD45.2 cells (1 3 106) or Cbs/ CD45.2 cells (1 3 106)
and WT CD45.1 cells (13 106) were infused into irradiated C57BL/6 WT mice.
Eight weeks later, mice were sacrificed and analyzed via flow cytometry.
Dot Blot Assay
DNA was diluted to 100 ng/ml and a dilution series was performed; then, 1 ml
was spotted on a 0.45 mm pore size positively charged nylon membrane.
The membrane was air-dried completely on a paper towel for 10 min at
room temperature, followed by baking in a vacuum oven (80C) for 2 hr. The
membrane was blocked in 5% milk/TBS/0.1%Tween-20 for 1 hr, followed
by incubation with 5hmC or 5mC antibodies in TBST/0.1% BSA overnight at
4C overnight. Then they were treated with horseradish peroxidase-conju-
gated rabbit or mouse IgG (Santa Cruz) (1:10,000) for 1 hr, enhanced with a
SuperSignal West Pico Chemiluminescent Substrate (Pierce), and exposed
on BIOMAX MR films (Kodak).
Microarray
Total RNAs were extracted from control and Cbs/ CD4+ T cells with an
RNeasy kit (QIAGEN). Microarray assays were performed at the Genome
Center of Children’s Hospital, Los Angeles, using Mouse Gene 1.0 ST arrays
(Affymetrix). The global gene expression difference was analyzed by Partek
Genomics Suite and Ingenuity Pathway Analysis (IPA) software. Global gene
expression profiles rank ordered by relative fold-change values were analyzed
using Gene Set Enrichment Analysis software (Broad Institute, MIT).
Statistical Analysis
Significance was determined by independent two-tailed Student’s t tests or
one-way analysis of variance (ANOVA) using SPSS 18.0 software. Kaplan-Me-
ier survival curves were constructed and analyzed by a log-rank test. At least
four mice were randomly assigned to each group. Exact number of mice used
in each group was indicated in the figure legends. Data were assessed for
normal distribution and similar variance between groups prior to further statis-
tical analysis. p values less than 0.05 were considered significant.ACCESSION NUMBERS
The Gene Expression Omnibus accession number for control and Cbs/
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